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OBJECTIVE — Adiponectin has been postulated to affect lipid and insulin signal transduc-
tion pathways. We evaluated the relationships of plasma adiponectin with lipoprotein mean
particle size and subclass concentrations, independent of obesity and insulin sensitivity.
RESEARCH DESIGN AND METHODS — A cross-sectional analysis of 884 young
Israeli adults who participated in the population-based Jerusalem Lipid Research Clinic (LRC)
study was conducted. Lipoprotein particle size was assessed using proton nuclear magnetic
resonance.
RESULTS — In multivariable linear regression models that included sex, BMI, waist circum-
ference, homeostasis model assessment of insulin resistance, and leptin, adiponectin was asso-
ciated with mean LDL size (standardized regression coefﬁcient B  0.20; P  0.001), VLDL size
(B  0.12; P  0.001), and HDL size (B  0.06; P  0.013). Adiponectin was inversely
related to large VLDL (P  0.001) but positively to small VLDL (P  0.02), inversely related to
small LDL (P  0.006) but positively to large LDL (P  0.001), and positively related to large
HDL (P  0.001) subclass concentrations.
CONCLUSIONS — Adiponectin is favorably associated with lipoprotein particle size and
subclass distribution independent of adiposity and insulin sensitivity.
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A
diponectin is a fat-derived adipocy-
tokine (1,2) that is strongly associ-
ated with insulin sensitivity and
favorablecardiovascularoutcomes.Given
that insulin resistance is associated with
reduced adiponectin levels (3), we hy-
pothesized that adiponectin may have a
direct role in hepatic lipoprotein metabo-
lism. Thus, the aim of this study was to
evaluate the relationships of adiponectin
with lipoprotein particle size, indepen-
dent of the degree of obesity and insulin
sensitivity, in a population-based sample
of healthy young adults.
RESEARCH DESIGN AND
METHODS— The Jerusalem Lipid
Research Clinic (LRC) prevalence study
has previously been described (4). In a
follow-upstudyofasex-stratiﬁedrandom
sample, we examined 570 men (73% re-
sponse) and 314 women (68%) aged
28–32 years, as previously reported (5).
Lipoprotein particle size analysis
used a 400-MHz proton nuclear mag-
netic resonance analyzer (LipoScience,
Raleigh, NC) (6). Adiponectin was ana-
lyzed using an in-house immunoﬂuoro-
metric assay (TRIFMA) as previously
described (7). Plasma leptin and insulin
concentrations were determined by ra-
dioimmunometric methods (Linco, St.
Charles,MO).Sex-speciﬁcPearsoncorre-
lations, partial correlations, and multiva-
riable linear regression modeling were
used. Regression results are expressed as
standardized coefﬁcient B. Collinearity
tolerances were acceptable.
RESULTS— The study population in-
cluded 884 young adults (570 men and
314 women; mean  SD age 30.1  0.8
years). Men had greater BMI than women
(25.1  3.6 vs. 23.8  3.9 kg/m
2; P 
0.001), whereas women had greater adi-
ponectin (8.9  3.4 vs. 6.4  2.6 mg/l;
P  0.001) and leptin concentrations
(13.2  8.3 vs. 5.1  3.5 g/l; P 
0.001).
Adiponectin was associated with li-
poprotein mean particle size in both
sexes. Its strongest relation in men was an
inverse association with VLDL size (r 
0.39; P  0.001) that persisted after
adjustment for BMI, waist circumference,
and homeostasis model assessment of in-
sulin resistance (HOMA-IR) (r  0.28;
P  0.001). This relation was weaker in
women (r  0.21; P  0.001) and was
attenuated by adjustment (r  0.12;
P  0.05). A positive association of adi-
ponectin with HDL and LDL particle size
evident in both sexes (r  0.30–0.35)
remained signiﬁcant after adjustment.
VLDL, LDL, and HDL particle sizes
were introduced separately as dependent
variables in backward stepwise multivari-
able linear regression models that in-
cluded sex, BMI, waist circumference,
HOMA-IR, the relevant plasma lipid or
lipoprotein (triglycerides, HDL choles-
terol,orLDLcholesterol),leptin,andadi-
ponectin. Adiponectin was signiﬁcantly
inversely associated with VLDL size (B 
0.12; P  0.001), whereas waist cir-
cumference (B  0.12; P  0.001),
HOMA-IR (B  0.09; P  0.002), and
triglycerides (B  0.58; P  0.001) were
positively associated (model R
2  0.57).
Adiponectin was associated with larger
LDL particle size (B  0.20; P  0.001),
whereaswaistcircumference(B0.31;
P  0.001) and sex (B  0.20; P 
0.001) were associated with smaller par-
ticle size (model R
2  0.32). Adiponectin
(B  0.06; P  0.013) and leptin (B 
0.10; P  0.001) showed opposite as-
sociations with HDL particle size. HDL
cholesterol was strongly associated with
larger HDL particle size (B  0.58; P 
0.001), whereas waist circumference
(B  0.14; P  0.001), HOMA-IR (B 
0.04; P  0.06), and male sex (B 
0.25; P  0.001) were associated with
smaller HDL particles (modelR
2  0.69).
We stratiﬁed the study sample into
tertiles of lipoprotein subclasses and dis-
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in each tertile of a lipoprotein subclass
(i.e., large, intermediate, and small) while
adjusting for sex, waist circumference,
BMI,andHOMA-IR.AsshowninFig.1A,
the adiponectin concentrations differed
substantially between tertiles of large
VLDLs and were inversely associated
with increasing concentrations of large
VLDLparticles(B0.19;Pfortrend
0.001). In contrast, adiponectin was
highest in the upper small VLDL tertile
within each large VLDL tertile category (P
for trend  0.02). Adiponectin was high-
est in the upper large LDL tertile (P for
trend  0.001) (Fig. 1B). In contrast,
within each large LDL tertile, adiponectin
decreased consistently with increasing
concentrations of small LDL particles (P
for trend  0.009). Adiponectin was
positively associated with concentrations
of large HDLs (P for trend  0.001) (Fig.
1C)butwasnotrelatedtosmallHDLpar-
ticle concentrations. Thus, adiponectin
concentration showed signiﬁcant con-
trasting associations with small and large
VLDL and LDL subclasses but was associ-
ated with only large HDL and not small
HDL particles.
We modeled adiponectin and leptin
separately as dependent variables in a
backward stepwise procedure that in-
cluded all lipoprotein subclasses, anthro-
pometric measures (BMI and waist
circumference), and HOMA-IR. In men,
adiponectin was independently inversely
associated with concentrations of large
VLDLs and positively associated with
small VLDLs and large and intermediate
HDLs. Leptin was positively associated
only with small VLDLs and adiponectin
after adjustment for anthropometric
measures and HOMA-IR. In women,
adiponectin showed an independent pos-
itive association only with large HDLs,
whereas leptin was inversely associated
with large VLDLs and positively with
small and intermediate HDLs.
CONCLUSIONS — This analysis, in
ostensibly healthy young adults, demon-
strates a substantial association between
plasma adiponectin and lipoprotein par-
ticle size. Adiponectin was associated
with mean particle size of the three li-
poprotein moieties after adjustment for
measures of obesity, insulin sensitivity,
leptin, and chemically measured relevant
lipoprotein (triglycerides and HDL or
LDL cholesterol). In addition, adiponec-
tin was signiﬁcantly linked to LDL and
Figure 1—Adjusted plasma adiponectin concentration as a function of lipoprotein subclass ter-
tilesadjustedforsex,waistcircumference,BMI,andHOMA-IR.A:Thecohortdividedintotertiles
of large VLDL concentrations is shown. Each of these tertiles is subdivided into tertiles of small
VLDL concentrations.  , the lowest tertile (tert); u, the middle tertile; and f, the upper tertile of
smallVLDL.B:ThecohortdividedintotertilesoflargeLDLconcentrationsisshown;eachofthese
tertiles is subdivided into tertiles of small LDL concentrations.  , the lowest tertile; u, the middle
tertile; and f, the upper tertile of small LDL. C: The cohort divided into tertiles of large HDL
concentrations is shown; each of these tertiles is subdivided into tertiles of small HDL concentra-
tions.  , the lowest tertile; u, the middle tertile; and f, the upper tertile of small HDL. *P for
trend  0.001 and 0.02 for large VLDL and small VLDL median tertile values, respectively. **P
fortrend0.001and0.009forlargeLDLandsmallLDLmediantertilevalues,respectively.***P
for trend  0.001 for large HDL median tertile values.
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adiponectin concentrations associated
with lower concentrations of large LDLs
and higher concentrations of small
LDLs. Such associations have previ-
ously been described in the context of
insulin resistance and obesity (8); how-
ever, our ﬁndings shed further light on
these relations because we show that
adiponectin levels are inversely associ-
ated with the concentrations of small
LDL and large VLDL particles indepen-
dent of insulin sensitivity, obesity, and
body fat distribution.
The presence of elevated levels of
small, dense LDL particles seems to be
associated with increased levels of large
VLDL particles and is closely associated
with insulin resistance (9). Our results
show that those subjects with greater
concentrations of large VLDL particles
had reduced adiponectin levels, whereas
the opposite was found for small VLDL
particles. Thus, the clustering of elevated
triglycerides (as a result of increased large
VLDL production) and small, dense LDL
particles in the context of insulin resis-
tance and obesity may be mediated by
adiponectin that is typically reduced in
this clinical setting (10,11), although
the cross-sectional nature of this study
cannot resolve directionality. Thus, the
seemingly protective role of adiponec-
tin against cardiovascular diseases and
diabetes may not necessarily be medi-
atedthroughitsassociationwithinsulin
sensitivity or obesity but, rather, could
reﬂect an independent effect on lipo-
protein metabolism.
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